US2018345030A1PendingUtilityA1
Ionized gas for medical treatment
Est. expiryMay 9, 2028(~1.8 yrs left)· nominal 20-yr term from priority
Inventors:John Wetling
A61N 1/44
35
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for treatment of a pathology-affected site in a subject, the method comprising providing said site with a net electrical charge for a period of time by subjecting the subject to a flux of ionized gas molecules whereby is provided an electrical current between said site and tissue outside said site.
Claims
exact text as granted — not AI-modified1 . A method for treatment of a pathology-affected site in a subject, the method comprising providing said site with a net electrical charge for a period of time by subjecting the subject to a flux of ionized gas molecules whereby is provided an electrical current between said site and tissue outside said site.
2 . The method according to claim 1 , wherein said site is selected from the group consisting of a wound area; injured tissue such as injured bone tissue, injured tendon, injured ligament tissue, injured peripheral or central nerves; a site exhibiting localized pain; a site exhibiting edema; a solid malignant tumor and a localized non-solid malignant tumor.
3 . The method according to claim 2 , wherein said wound area is a slowly healing or non-healing wound area.
4 . The method according to claim 3 , wherein healing of the wound area is facilitated by said treatment.
5 . The method according to claim 1 , wherein the net electrical charge establishes an electrical current between the surface of the wound area and underlying tissue.
6 . The method according to claim 1 , wherein said gas is derived from atmospheric air.
7 . The method according to claim 1 , wherein said net electrical charge is negative.
8 . The method according to claim 1 , wherein the ionized gas molecules are negatively charged oxygen molecules.
9 . The method according to claim 1 , wherein said net electrical charge is positive.
10 . The method according to claim 9 , wherein the ionized gas molecules are positively charged Nitrogen molecules.
11 . The method according to claim 1 , wherein a discharge electrode is located outside said site on or in the subject's body so as to sustain the electrical current between said site and the discharge electrode.
12 . The method according to claim 1 , wherein the phase of the electrical current kept substantially constant over time during treatment.
13 . The method according to claim 1 , wherein the direction of the electrical current is shifted at least once during treatment by shifting the charge of the ionized gas molecules.
14 . The method according to claim 13 , wherein the polarity of the discharge electrode is shifted substantially simultaneously with shifting the charge of the ionized gas molecules.
15 . The method according to claim 1 , wherein the flux of ionized gas molecules is projected directly onto said site or to the surface of the subject's body covering said site.
16 . The method according to claim 1 , wherein the ionized gas molecules are provided by means of a gas ion transmitting device.
17 . The method according to claim 1 , wherein the electrical current is at least 0.1 μA.
18 . The method according to claim 1 , wherein the electrical current is at most 100 μA.
19 . The method according to claim 1 , wherein the treatment time is at least 1 minute.
20 . The method according to claim 1 , wherein the treatment time is at most 24 hours.
21 . A method of treating a subject suffering from asthma or other disease characterized by a pathology involving histamine release by mast cells or basophilic granulocytes, said method comprising subjecting the subject to a flux of ionized gas molecules for a period of time, said ionized gas molecules having a net positive or negative charge.
22 . The method according to claim 21 , wherein the flux is projected onto the thorax and/or the face of the subject.
23 . The method according to claim 22 , wherein the method features are as defined in any one of claims 6 - 14 and 16 - 20 .
24 . (canceled)Join the waitlist — get patent alerts
Track US2018345030A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.